PRRT2 and cancer: Considering that TPA and other PKC-activating compounds can induce cellular senescence in certain cancer lines, it is possible that exposure to both DNA damage and TPA simultaneously in this model results in exacerbated expression of senescence associated gene products involved in extracellular signaling and inflammation [34].